TY  - GEN
AU  - Rapoport,A P
AU  - Meisenberg,B
AU  - Sarkodee-Adoo,C
AU  - Fassas,A
AU  - Frankel,S R
AU  - Mookerjee,B
AU  - Takebe,N
AU  - Fenton,R
AU  - Heyman,M
AU  - Badros,A
AU  - Kennedy,A
AU  - Jacobs,M
AU  - Hudes,R
AU  - Ruehle,K
AU  - Smith,R
AU  - Kight,L
AU  - Chambers,S
AU  - MacFadden,M
AU  - Cottler-Fox,M
AU  - Chen,T
AU  - Phillips,G
AU  - Tricot,G
TI  - Autotransplantation for advanced lymphoma and Hodgkin's disease followed by post-transplant rituxan/GM-CSF or radiotherapy and consolidation chemotherapy
SN  - 0268-3369
PY  - 2002///0709
KW  - Adult
KW  - Aged
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Combined Modality Therapy
KW  - Disease-Free Survival
KW  - Female
KW  - Granulocyte-Macrophage Colony-Stimulating Factor
KW  - Hematopoietic Stem Cell Transplantation
KW  - Hodgkin Disease
KW  - drug therapy
KW  - Humans
KW  - Immunotherapy
KW  - Lymphoma, Non-Hodgkin
KW  - Male
KW  - Middle Aged
KW  - Rituximab
KW  - Transplantation, Autologous
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/sj.bmt.1703363
ER  -